DK481585A - Farmaceutisk praeparat indeholdende anthracyclinglycosider - Google Patents

Farmaceutisk praeparat indeholdende anthracyclinglycosider Download PDF

Info

Publication number: DK481585A
Authority: DK; Denmark
Prior art keywords: anthracycling; lycosides; pharmaceutical preparation; preparation containing; pharmaceutical
Prior art date: 1984-10-22

Application number

DK481585A

Other languages

English (en)

Other versions

DK481585D0 (da

DK165620B (da

DK165620C (da

Inventor

Gaetano Gatti

Diego Oldani

Carlo Confalonieri

Luciano Gambini

Original Assignee

Erba Farmitalia

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1984-10-22

Filing date

1985-10-21

Publication date

1986-04-23

1985-10-21 Application filed by Erba Farmitalia filed Critical Erba Farmitalia

1985-10-21 Publication of DK481585D0 publication Critical patent/DK481585D0/da

1986-04-23 Publication of DK481585A publication Critical patent/DK481585A/da

1992-12-28 Publication of DK165620B publication Critical patent/DK165620B/da

1993-06-01 Application granted granted Critical

1993-06-01 Publication of DK165620C publication Critical patent/DK165620C/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oil, Petroleum & Natural Gas (AREA)
Molecular Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Saccharide Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DK481585A 1984-10-22 1985-10-21 Frysetoerret farmaceutisk praeparat indeholdende anthracyclinglycosider og et cosolubiliserende middel og fremgangsmaade til fremstilling heraf, anvendelse af praeparatet til fremstilling af et tumormiddel samt fremgangsmaade til fremstilling af en rekonstitueret injicerbar oploesning af praeparatet DK165620C (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB8426672		1984-10-22
GB848426672A GB8426672D0 (en)	1984-10-22	1984-10-22	Pharmaceutical compositions

Publications (4)

Publication Number	Publication Date
DK481585D0 DK481585D0 (da)	1985-10-21
DK481585A true DK481585A (da)	1986-04-23
DK165620B DK165620B (da)	1992-12-28
DK165620C DK165620C (da)	1993-06-01

Family

ID=10568553

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK481585A DK165620C (da)	1984-10-22	1985-10-21	Frysetoerret farmaceutisk praeparat indeholdende anthracyclinglycosider og et cosolubiliserende middel og fremgangsmaade til fremstilling heraf, anvendelse af praeparatet til fremstilling af et tumormiddel samt fremgangsmaade til fremstilling af en rekonstitueret injicerbar oploesning af praeparatet

Country Status (35)

Country	Link
US (4)	US4675311A (da)
JP (1)	JPH0611700B2 (da)
KR (1)	KR920005813B1 (da)
CN (1)	CN85107562B (da)
AT (1)	AT401345B (da)
AU (1)	AU572003B2 (da)
BE (1)	BE903484A (da)
BG (1)	BG60934B2 (da)
CA (1)	CA1248453A (da)
CH (1)	CH667594A5 (da)
CS (1)	CS270421B2 (da)
DE (1)	DE3536896C2 (da)
DK (1)	DK165620C (da)
ES (1)	ES8605374A1 (da)
FI (2)	FI853913A7 (da)
FR (1)	FR2571966B1 (da)
GB (2)	GB8426672D0 (da)
GR (1)	GR852549B (da)
HK (1)	HK94390A (da)
HU (1)	HU197988B (da)
IE (1)	IE56992B1 (da)
IL (1)	IL76732A (da)
IT (1)	IT1186779B (da)
MY (1)	MY103956A (da)
NL (1)	NL191308C (da)
NO (1)	NO170616C (da)
NZ (1)	NZ213885A (da)
PH (1)	PH23982A (da)
PT (1)	PT81347B (da)
RU (2)	RU1836088C (da)
SE (1)	SE467520B (da)
SG (1)	SG80290G (da)
UA (2)	UA19169A (da)
YU (1)	YU46160B (da)
ZA (1)	ZA858033B (da)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2200047B (en) *	1986-12-05	1990-11-21	Erba Carlo Spa	Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
US5977082A (en) *	1985-08-02	1999-11-02	Pharmacia & Upjohn Company	Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
US5124317A (en) *	1985-08-02	1992-06-23	Farmitalia Carlo Erba S.P.A.	Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
US5124318A (en) *	1985-08-02	1992-06-23	Farmitalia Carlo Erba S.R.L.	Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
JP2603480B2 (ja) *	1987-08-05	1997-04-23	住友製薬株式会社	安定化されたアンスラサイクリン系製剤
DE3801178A1 (de) *	1988-01-18	1989-07-27	Hoechst Ag	Stabilisierte trockenzubereitung zytostatisch wirksamer anthracyclin-antibiotika und verfahren zu ihrer herstellung
US6300362B1 (en)	1990-07-25	2001-10-09	Novartis Ag (Formerly Sandoz Ltd.)	Stabilized pharmaceutical compositions comprising acid donors
US6471943B1 (en)	1996-12-30	2002-10-29	Battelle Pulmonary Therapeutics, Inc.	Formulation and method for treating neoplasms by inhalation
US5942508A (en) *	1997-02-04	1999-08-24	Senju Pharmaceutical Co., Ltd.	Method for solubilizing pyridonecarboxylic acid solubilizer thereof and aqueous solution containing solubilized pyridonecarboxylic acid
RU2292216C2 (ru) *	2000-10-31	2007-01-27	Фарма Мар, С.А.	Кахалалид f
BRPI0307802B8 (pt)	2002-02-22	2021-05-25	Merck Sharp & Dohme	formulação farmacêutica compreendendo temozolomida, processo para a produção da mesma, bem como artigo fabricado contendo pó liofilizado compreendendo temozolomida
EP1474995B1 (en) *	2003-05-06	2012-11-14	Gumlink A/S	A method for producing chewing gum granules, a gum composition extruder and granulating system, and a chewing gum product
US20090099346A1 (en) *	2003-07-02	2009-04-16	Victor Matvienko	Thermally stable crystalline epirubicin hydrochloride
EP1638509B1 (en) *	2003-07-02	2015-12-30	Solux Corporation	Thermally stable crystalline epirubicin hydrochloride and method of making the same
US7314862B2 (en) *	2003-09-25	2008-01-01	Astellas Pharma Inc.	Antitumor agent
RU2262923C2 (ru) *	2003-12-25	2005-10-27	Государственное образовательное учреждение высшего профессионального образования Курский государственный медицинский университет Министерства здравоохранения Российской Федерации	Иммобилизованная форма доксорубицина
US7388083B2 (en) *	2005-03-07	2008-06-17	Solux Corporation	Epimerization of 4′-C bond and modification of 14-CH3-(CO)-fragment in anthracyclin antibiotics
KR20070088447A (ko) *	2005-05-11	2007-08-29	시코르, 인크.	안정한 동결건조된 안트라사이클린 글리코시드
EP2397034A1 (en)	2005-07-14	2011-12-21	Lithera, Inc.	Sustained Release Enhanced Lipolytic Formulation for Regional Adipose Tissue Treatment
US9035032B2 (en) *	2005-12-13	2015-05-19	Solux Corporation	Method for preparing 4-demethyldaunorubicin
US8802830B2 (en) *	2005-12-20	2014-08-12	Solux Corporation	Synthesis of epirubicin from 13-dihydrodaunorubicine
US8148338B2 (en) *	2006-02-22	2012-04-03	Supratek Pharma Inc.	Doxorubicin formulations for anti-cancer use
US7470672B2 (en) *	2006-07-31	2008-12-30	Savvipharm Inc.	Compositions and methods of reducing tissue levels of drugs when given as orotate derivatives
BRPI0811248A2 (pt) *	2007-05-16	2014-11-04	Ktb Tumorforschungs Gmbh	Formulação de antraciclina de baixa viscosidade.
KR101511398B1 (ko) *	2007-09-04	2015-04-24	메이지 세이카 파루마 가부시키가이샤	주사제, 주사 용액, 및 주사 키트 제제
BRPI0818860A2 (pt) *	2007-10-26	2015-04-22	Pfizer Prod Inc	Idarubicina para o tratamento de linfoma em um cão
US8357785B2 (en) *	2008-01-08	2013-01-22	Solux Corporation	Method of aralkylation of 4′-hydroxyl group of anthracylins
US9132084B2 (en)	2009-05-27	2015-09-15	Neothetics, Inc.	Methods for administration and formulations for the treatment of regional adipose tissue
SG2014014351A (en) *	2010-01-15	2014-07-30	Lithera Inc	Lyophilized cake formulations
UA111822C2 (uk)	2010-11-24	2016-06-24	Общєство С Огранічєнной Отвєтствєнностью "Новамедіка"	Монотерапевтичий препарат селективного ліпофільного бета-агоніста тривалої дії і спосіб косметичного лікування ожиріння і контурного випинання
DE102011103751A1 (de)	2011-05-31	2012-12-06	Heraeus Precious Metals Gmbh & Co. Kg	Kristallisierung von Epirubicinhydrochlorid
DE102011111991A1 (de) *	2011-08-30	2013-02-28	Lead Discovery Center Gmbh	Neue Cyclosporin-Derivate
DK2931042T3 (da)	2012-12-13	2021-06-07	Cytrx Corp	Anthracyclinformuleringer
NZ631022A (en)	2013-06-05	2018-05-25	Cytrx Corp	Cytotoxic agents for the treatment of cancer

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
YU33730B (en) *	1967-04-18	1978-02-28	Farmaceutici Italia	Process for preparing a novel antibiotic substance and salts thereof
US4039663A (en) *	1975-03-19	1977-08-02	Societa' Farmaceutici Italia S.P.A.	Daunomycins, process for their uses and intermediates
GB1506200A (en) *	1975-04-30	1978-04-05	Farmaceutici Italia	Glycosides
GB1567456A (en) *	1976-11-16	1980-05-14	Farmaceutici Italia	Daunomycin derivatives
GB2007645B (en) *	1977-10-17	1982-05-12	Stanford Res Inst Int	Benzyl anthracyclines and pharmaceutical compositions containing them
US4177264A (en) *	1977-10-17	1979-12-04	Sri International	N-benzyl anthracyclines
JPS563851A (en) *	1979-06-22	1981-01-16	Matsushita Electric Works Ltd	Fireplace in floor
JPS5756494A (en) *	1980-09-22	1982-04-05	Microbial Chem Res Found	New anthracyclin derivative
US4325947A (en) *	1981-05-12	1982-04-20	Farmitalia Carlo Erba S.P.A.	4-Demethoxy-4'-deoxydoxorubicin
IT1210476B (it) *	1981-05-28	1989-09-14	Erba Farmitalia	Antracicline.
US4438105A (en) *	1982-04-19	1984-03-20	Farmaitalia Carlo Erba S.P.A	4'-Iododerivatives of anthracycline glycosides
AU554416B2 (en) *	1982-05-24	1986-08-21	Farmitalia Carlo Erba S.P.A.	Anthracycline glycosides
US4464529A (en) *	1982-07-20	1984-08-07	Sri International	Analogues of morpholinyl daunorubicin and morpholinyl doxorubicin
CA1248944A (en) *	1982-09-28	1989-01-17	Gareth J. Thomas	Anthracycline glycosides
JPS5982395A (ja) *	1982-11-02	1984-05-12	Microbial Chem Res Found	アントラサイクリン化合物、その製造法およびその用途
GR79729B (da) *	1982-12-20	1984-10-31	Univ Ohio State Res Found
JPS6092212A (ja) *	1983-10-26	1985-05-23	Kyowa Hakko Kogyo Co Ltd	ドキソルビシン塩の製剤
US4537882A (en) *	1984-05-10	1985-08-27	Ohio State University	4-Demethoxy-3'-desamino-2'-halo-anthracycline and pharmaceutical composition containing same

1984
- 1984-10-22 GB GB848426672A patent/GB8426672D0/en active Pending
1985
- 1985-10-03 ES ES547578A patent/ES8605374A1/es not_active Expired
- 1985-10-08 FI FI853913A patent/FI853913A7/fi not_active Application Discontinuation
- 1985-10-15 HU HU853988A patent/HU197988B/hu unknown
- 1985-10-15 CN CN85107562A patent/CN85107562B/zh not_active Expired
- 1985-10-16 IT IT22507/85A patent/IT1186779B/it active Protection Beyond IP Right Term
- 1985-10-16 YU YU164485A patent/YU46160B/sh unknown
- 1985-10-16 US US06/788,158 patent/US4675311A/en not_active Expired - Lifetime
- 1985-10-16 FI FI854035A patent/FI86252C/fi not_active IP Right Cessation
- 1985-10-16 DE DE3536896A patent/DE3536896C2/de not_active Expired - Lifetime
- 1985-10-17 JP JP60230055A patent/JPH0611700B2/ja not_active Expired - Lifetime
- 1985-10-17 AU AU48805/85A patent/AU572003B2/en not_active Expired
- 1985-10-17 IL IL76732A patent/IL76732A/xx not_active IP Right Cessation
- 1985-10-17 CH CH4476/85A patent/CH667594A5/de not_active IP Right Cessation
- 1985-10-18 RU SU853964940A patent/RU1836088C/ru active
- 1985-10-18 ZA ZA858033A patent/ZA858033B/xx unknown
- 1985-10-18 PH PH32947A patent/PH23982A/en unknown
- 1985-10-18 AT AT0303285A patent/AT401345B/de not_active IP Right Cessation
- 1985-10-18 UA UA3964940A patent/UA19169A/uk unknown
- 1985-10-18 NZ NZ213885A patent/NZ213885A/en unknown
- 1985-10-18 UA UA5010680A patent/UA34419C2/uk unknown
- 1985-10-18 GB GB08525709A patent/GB2165751B/en not_active Expired
- 1985-10-21 NL NL8502869A patent/NL191308C/xx not_active IP Right Cessation
- 1985-10-21 BE BE0/215752A patent/BE903484A/fr not_active IP Right Cessation
- 1985-10-21 PT PT81347A patent/PT81347B/pt unknown
- 1985-10-21 CA CA000493459A patent/CA1248453A/en not_active Expired
- 1985-10-21 NO NO854194A patent/NO170616C/no not_active IP Right Cessation
- 1985-10-21 IE IE2593/85A patent/IE56992B1/en not_active IP Right Cessation
- 1985-10-21 DK DK481585A patent/DK165620C/da not_active IP Right Cessation
- 1985-10-21 FR FR8515596A patent/FR2571966B1/fr not_active Expired
- 1985-10-21 SE SE8504945A patent/SE467520B/sv not_active IP Right Cessation
- 1985-10-21 KR KR1019850007740A patent/KR920005813B1/ko not_active Expired
- 1985-10-22 CS CS857565A patent/CS270421B2/cs not_active IP Right Cessation
- 1985-10-22 GR GR852549A patent/GR852549B/el unknown
1986
- 1986-08-06 US US06/893,613 patent/US4840938A/en not_active Expired - Lifetime
1988
- 1988-12-30 MY MYPI88001588A patent/MY103956A/en unknown
1990
- 1990-09-26 US US07/588,526 patent/US5091372A/en not_active Expired - Lifetime
- 1990-09-28 US US07/590,536 patent/US5091373A/en not_active Expired - Lifetime
- 1990-10-03 SG SG802/90A patent/SG80290G/en unknown
- 1990-11-15 HK HK943/90A patent/HK94390A/xx not_active IP Right Cessation
1992
- 1992-01-30 RU SU5010680A patent/RU2101018C1/ru active
1994
- 1994-02-23 BG BG098530A patent/BG60934B2/bg unknown

Also Published As

Publication number	Publication date
IL76732A (en)	1989-07-31
NO854194L (no)	1986-04-23
US5091372A (en)	1992-02-25
NZ213885A (en)	1988-05-30
FR2571966A1 (fr)	1986-04-25
UA19169A (uk)	1997-12-25
AT401345B (de)	1996-08-26
IL76732A0 (en)	1986-02-28
YU46160B (sh)	1993-05-28
NO170616B (no)	1992-08-03
GB2165751A (en)	1986-04-23
DK481585D0 (da)	1985-10-21
FI853913A7 (fi)	1986-04-23
US4675311A (en)	1987-06-23
ATA303285A (de)	1996-01-15
CS756585A2 (en)	1989-11-14
CN85107562A (zh)	1986-07-23
IT1186779B (it)	1987-12-16
FI86252B (fi)	1992-04-30
ZA858033B (en)	1986-06-25
PT81347B (pt)	1987-11-11
SG80290G (en)	1990-11-23
FI854035L (fi)	1986-04-23
NL191308B (nl)	1994-12-16
GR852549B (da)	1986-02-24
SE467520B (sv)	1992-08-03
GB2165751B (en)	1988-08-17
CA1248453A (en)	1989-01-10
FI853913A0 (fi)	1985-10-08
DK165620B (da)	1992-12-28
FR2571966B1 (fr)	1988-04-15
RU2101018C1 (ru)	1998-01-10
IE56992B1 (en)	1992-02-26
US5091373A (en)	1992-02-25
HUT40759A (en)	1987-02-27
SE8504945D0 (sv)	1985-10-21
JPS61246129A (ja)	1986-11-01
HU197988B (en)	1989-07-28
AU572003B2 (en)	1988-04-28
KR920005813B1 (ko)	1992-07-20
RU1836088C (ru)	1993-08-23
ES8605374A1 (es)	1986-03-16
FI86252C (fi)	1992-08-10
FI854035A0 (fi)	1985-10-16
UA34419C2 (uk)	2001-03-15
DK165620C (da)	1993-06-01
HK94390A (en)	1990-11-23
BG60934B2 (bg)	1996-06-28
MY103956A (en)	1993-10-30
DE3536896A1 (de)	1986-04-24
ES547578A0 (es)	1986-03-16
NL191308C (nl)	1995-05-16
DE3536896C2 (de)	1996-11-14
IE852593L (en)	1986-04-22
AU4880585A (en)	1986-05-01
CH667594A5 (de)	1988-10-31
SE8504945L (sv)	1986-04-23
PH23982A (en)	1990-02-09
YU164485A (en)	1987-10-31
KR860003014A (ko)	1986-05-19
NO170616C (no)	1992-11-11
US4840938A (en)	1989-06-20
PT81347A (en)	1985-11-01
NL8502869A (nl)	1986-05-16
CN85107562B (zh)	1988-06-01
GB8525709D0 (en)	1985-11-20
JPH0611700B2 (ja)	1994-02-16
GB8426672D0 (en)	1984-11-28
IT8522507A0 (it)	1985-10-16
CS270421B2 (en)	1990-06-13
BE903484A (fr)	1986-04-21

Publication	Publication Date	Title
DK481585A (da)	1986-04-23	Farmaceutisk praeparat indeholdende anthracyclinglycosider
DK195988A (da)	1988-06-08	Farmaceutisk praeparat indeholdende mikrokapsler
DK546886D0 (da)	1986-11-14	Farmaceutisk praeparat
DK68392D0 (da)	1992-05-25	Farmaceutisk praeparat indeholdende cefuroximaxetil
DK237884D0 (da)	1984-05-11	Farmaceutisk praeparat
DK60885A (da)	1985-08-14	Oralt praeparat
IT1209615B (it)	1989-08-30	Composizione farmaceutica
DK288686D0 (da)	1986-06-19	Farmaceutiske praeparater
DK58983D0 (da)	1983-02-11	Farmaceutisk praeparat
IT1213453B (it)	1989-12-20	Composizione farmaceutica.
DK52086D0 (da)	1986-02-03	Farmaceutiske praeparater indeholdende ergotalkaloider
DK201785D0 (da)	1985-05-06	Topisk farmaceutisk praeparat
DK139388D0 (da)	1988-03-15	Farmaceutisk praeparat
DE3669656D1 (de)	1990-04-26	Azanaphthalene enthaltende arzneimittelzusammensetzungen.
IT1203737B (it)	1989-02-23	Composizioni farmaceutiche comprendenti 3-amminopropossi-indoli
DK639787A (da)	1988-06-10	Laegemiddelform indeholdende urapidil
DK453785D0 (da)	1985-10-04	Laegemiddel med grf-virkning
DK138888D0 (da)	1988-03-15	Farmaceutisk praeparat
SE8404468D0 (sv)	1984-09-06	Farmaceutisk beredning
DK428287D0 (da)	1987-08-17	Nasalt farmaceutisk praeparat
RO90578A2 (ro)	1986-12-10	Produs medicamentos fitoterapeutic hepatoprotector
RO92109A2 (ro)	1987-07-30	Procedeu de preparare azodicarboxamidei
SE8400086D0 (sv)	1984-01-10	Farmaceutisk komposition
BR6500407U (pt)	1986-11-18	Composicao medicinal
DK56484D0 (da)	1984-02-09	Farmaceutisk praeparat

Legal Events

Date	Code	Title	Description
2005-11-07	PUP	Patent expired